Back to Schonfeld Strategic Advisors LLC Schonfeld Strategic Advisors LLC

DYNDYN

Showing 7 of 10 quarters

Position history for Schonfeld Strategic Advisors LLCSchonfeld Strategic Advisors LLC's holdings in DYNE THERAPEUTICS INC

Yes. Schonfeld Strategic Advisors holds 134,752 shares of DYN (Dyne Therapeutics), worth $3M, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$3M

Current Shares

134,752

Total Value Change

+$1.7M

Total Shares Change

+98,400

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
134,752
—
$3M0.0%$22.21
36
2025-Q4
Exited
0
-100.0%
$00.0%$19.20
0
2025-Q3
Increased
415,927
+24.7%
$5.3M0.0%$12.37
33
2025-Q2
Increased
333,453
+127.9%
$3.2M0.0%$9.57
43
2025-Q1
New
146,294
—
$1.5M0.0%$11.45
35
2024-Q4
Exited
0
-100.0%
$00.0%$23.65
0
2024-Q3
Decreased
36,352
-68.4%
$1.3M0.0%$33.83
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used